Published in J Immunol Methods on January 01, 1980
Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 5.80
Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature (1982) 5.11
Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A (1982) 4.37
Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product. Nature (1991) 3.68
Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. J Biol Chem (1994) 3.03
A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J Exp Med (1995) 2.88
Selective immortalization of murine macrophages from fresh bone marrow by a raf/myc recombinant murine retrovirus. Nature (1986) 2.64
Oncogene ect2 is related to regulators of small GTP-binding proteins. Nature (1993) 2.34
Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype. Proc Natl Acad Sci U S A (1983) 2.04
A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr. New Biol (1991) 1.74
Isolation of a new human oncogene from a diffuse B-cell lymphoma. Nature (1985) 1.68
Dbl and Vav mediate transformation via mitogen-activated protein kinase pathways that are distinct from those activated by oncogenic Ras. Mol Cell Biol (1994) 1.60
Differential inhibition of IL-1 and TNF-alpha mRNA expression by agents which block second messenger pathways in murine macrophages. J Immunol (1988) 1.55
The identification and characterization of a GDP-dissociation inhibitor (GDI) for the CDC42Hs protein. J Biol Chem (1992) 1.52
Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst (1989) 1.44
The pleckstrin homology domain mediates transformation by oncogenic dbl through specific intracellular targeting. J Biol Chem (1996) 1.40
Molecular cloning and characterization of the human dbl proto-oncogene: evidence that its overexpression is sufficient to transform NIH/3T3 cells. EMBO J (1988) 1.39
Frequent activation of c-kis as a transforming gene in fibrosarcomas induced by methylcholanthrene. Science (1983) 1.38
Functional requirement of the hypoxia-responsive element in the activation of the inducible nitric oxide synthase promoter by the iron chelator desferrioxamine. J Biol Chem (1997) 1.33
Macrophage-colony-stimulating factor (CSF-1) induces proliferation, chemotaxis, and reversible monocytic differentiation in myeloid progenitor cells transfected with the human c-fms/CSF-1 receptor cDNA. Proc Natl Acad Sci U S A (1990) 1.31
A murine macrophage cell line, immortalized by v-raf and v-myc oncogenes, exhibits normal macrophage functions. Eur J Immunol (1987) 1.25
Genetic resistance/susceptibility to mycobacteria: phenotypic expression in bone marrow derived macrophage lines. J Leukoc Biol (1991) 1.24
Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med (1990) 1.19
Autoinhibition mechanism of proto-Dbl. Mol Cell Biol (2001) 1.18
Potential requirement of a functional double-stranded RNA-dependent protein kinase (PKR) for the tumoricidal activation of macrophages by lipopolysaccharide or IFN-alpha beta, but not IFN-gamma. J Immunol (1995) 1.17
Regulation of JAK3 expression in human monocytes: phosphorylation in response to interleukins 2, 4, and 7. J Exp Med (1995) 1.14
Transforming growth factor beta downregulates interleukin-1 (IL-1)-induced IL-6 production by human monocytes. Blood (1990) 1.13
Flavopiridol, a protein kinase inhibitor, down-regulates hypoxic induction of vascular endothelial growth factor expression in human monocytes. Cancer Res (1999) 1.12
Interferon activates macrophages to produce plasminogen activator. J Interferon Res (1982) 1.11
Endotoxin requirement for macrophage activation by lymphokines in a rapid microcytotoxicity assay. J Immunol Methods (1980) 1.10
Augmentation of GG2EE macrophage cell line-mediated anti-Candida activity by gamma interferon, tumor necrosis factor, and interleukin-1. Infect Immun (1990) 1.10
Nuclear factor kB is activated by arachidonic acid but not by eicosapentaenoic acid. Biochem Biophys Res Commun (1996) 1.08
Modulation of oncogenic DBL activity by phosphoinositol phosphate binding to pleckstrin homology domain. J Biol Chem (2001) 1.06
Pleiotropic effects of transforming growth factor-beta on cells of the immune system. Ann N Y Acad Sci (1993) 1.05
Interferon-gamma upregulates interleukin-8 gene expression in human monocytic cells by a posttranscriptional mechanism. Blood (1994) 1.05
Tumor necrosis factor-alpha-dependent production of reactive nitrogen intermediates mediates IFN-gamma plus IL-2-induced murine macrophage tumoricidal activity. J Immunol (1992) 1.05
IL-2 induces IL-6 production in human monocytes. J Immunol (1992) 1.03
IL-2 up-regulates but IFN-gamma suppresses IL-8 expression in human monocytes. J Immunol (1993) 1.02
Cytokine gene expression during the generation of human lymphokine-activated killer cells: early induction of interleukin 1 beta by interleukin 2. Cancer Res (1989) 1.02
Generation of macrophage cell line from fresh bone marrow cells with a myc/raf recombinant retrovirus. Cancer Biochem Biophys (1989) 1.01
Regulation of inducible nitric oxide synthase expression in IFN-gamma-treated murine macrophages cultured under hypoxic conditions. J Immunol (1996) 1.00
The N-terminal region of proto-dbl down regulates its transforming activity. Oncogene (1989) 1.00
Posttranscriptional control of human gamma interferon gene expression in transfected mouse fibroblasts. Mol Cell Biol (1986) 0.99
c-fos mRNA expression in macrophages is downregulated by interferon-gamma at the posttranscriptional level. Mol Cell Biol (1991) 0.98
The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1 beta in macrophages. J Immunol (2000) 0.97
Interleukin-4 inhibits indoleamine 2,3-dioxygenase expression in human monocytes. Blood (1994) 0.97
Detection of activated proto-oncogenes in N-nitrosodiethylamine-induced liver tumors: a comparison between B6C3F1 mice and Fischer 344 rats. Carcinogenesis (1988) 0.97
Mechanisms of lymphocyte activation: linkage between early protein synthesis and late lymphocyte proliferation. J Immunol (1980) 0.97
Potent activation of mouse macrophages by recombinant interferon-gamma. Cancer Res (1984) 0.96
Characterization of IL-2 receptor expression and function on murine macrophages. J Immunol (1990) 0.96
Macrophages as regulators of immune responses against tumors. Adv Exp Med Biol (1979) 0.96
Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid. J Biol Chem (1994) 0.95
A functional protein kinase C is required for induction of 2-5A synthetase by recombinant interferon-alpha A in Daudi cells. J Biol Chem (1989) 0.93
Distinct involvement of cdc42 and RhoA GTPases in actin organization and cell shape in untransformed and Dbl oncogene transformed NIH3T3 cells. Oncogene (2000) 0.93
Augmentation of c-fos mRNA expression by activators of protein kinase C in fresh, terminally differentiated resting macrophages. Mol Cell Biol (1987) 0.93
The effect of cytochalasin B, colchicine and vinblastine on the adhesion of Trichomonas vaginalis to glass surfaces. Int J Parasitol (1975) 0.92
Effect of extracorporeal shock wave on proliferation and differentiation of equine adipose tissue-derived mesenchymal stem cells in vitro. Am J Stem Cells (2013) 0.91
Interleukin-2 and human monocyte activation. J Leukoc Biol (1995) 0.90
Erythroid differentiation and modulation of c-myc expression induced by antineoplastic drugs in the human leukemic cell line K562. Cancer Res (1987) 0.90
An electrogenic amino acid transporter in the apical membrane of cultured human bronchial epithelial cells. Am J Physiol (1998) 0.90
Tumoricidal alveolar macrophage and tumor infiltrating macrophage cell lines. Int J Cancer (1991) 0.90
The human dbl-proto-oncogene product is a cytoplasmic phosphoprotein which is associated with the cytoskeletal matrix. Oncogene (1989) 0.89
Lipopolysaccharide, but not IFN-gamma, down-regulates c-fms mRNA proto-oncogene expression in murine macrophages. J Immunol (1990) 0.89
Inhibition of retroviral mRNA expression in the murine macrophage cell line GG2EE by biologic response modifiers. J Immunol (1988) 0.89
Identification of the protein encoded by the human diffuse B-cell lymphoma (dbl) oncogene. Proc Natl Acad Sci U S A (1986) 0.87
Interferon-alpha, -beta, and -gamma augment the levels of rRNA precursors in peritoneal macrophages but not in macrophage cell lines and fibroblasts. J Immunol (1987) 0.87
Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages. J Immunol (1993) 0.87
Engineering of macrophages to produce IFN-gamma in response to hypoxia. J Immunol (2001) 0.86
IL-2 enhances c-fms expression in human monocytes. J Immunol (1990) 0.86
IL-4 inhibits the costimulatory activity of IL-2 or picolinic acid but not of lipopolysaccharide on IFN-gamma-treated macrophages. J Immunol (1991) 0.85
IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. J Exp Med (1994) 0.85
Generation of a murine monoclonal antibody that detects the fos oncogene product. Anal Biochem (1987) 0.85
In vivo activation of macrophages but not natural killer cells by picolinic acid (PLA). J Immunopharmacol (1984) 0.85
Inhibition of replication of virus-transformed fibroblasts by antibodies to RNA. Cancer Res (1975) 0.85
Regulation by interleukin-2 (IL-2) and interferon gamma of IL-2 receptor gamma chain gene expression in human monocytes. Blood (1994) 0.84
Comparison of five short-term assays that measure nonspecific cytotoxicity mediated to tumor cells by activated macrophages. J Leukoc Biol (1986) 0.84
Functional role for the myeloid differentiation antigen CD14 in the activation of human monocytes by IL-2. J Immunol (1997) 0.84
Requirement for protein synthesis for induction of macrophage tumoricidal activity by IFN-alpha and IFN-beta but not by IFN-gamma. J Immunol (1984) 0.84
Antiproliferative activity of picolinic acid due to macrophage activation. Drugs Exp Clin Res (1987) 0.83
Role of protein synthesis in the activation of cytotoxic mouse macrophages by lymphokines. Cell Immunol (1984) 0.83
Induction of macrophage glutamine: fructose-6-phosphate amidotransferase expression by hypoxia and by picolinic acid. Int J Immunopathol Pharmacol (2007) 0.83
Regulation of IL-2 receptor subunit genes in human monocytes. Differential effects of IL-2 and IFN-gamma. J Immunol (1992) 0.83
Suppression of proliferative response and lymphokine production during the progression of a spontaneous tumor. Cancer Res (1979) 0.83
IL-2 induction of IL-1 beta mRNA expression in monocytes. Regulation by agents that block second messenger pathways. J Immunol (1989) 0.83
New high-performance liquid chromatographic method for the detection of picolinic acid in biological fluids. J Chromatogr B Biomed Sci Appl (2001) 0.83
Metabolic requirements for the in vitro augmentation of mouse natural killer activity by interferon. Cell Immunol (1981) 0.82
Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines. J Immunol (1980) 0.82
Human Harvey-ras is biochemically different from Kirsten- or N-ras. Oncogene (1991) 0.82
Selective inhibition by monosaccharides of tumor cell cytotoxicity mediated by mouse macrophages, macrophage-like cell lines, and natural killer cells. Int J Cancer (1983) 0.82
Distribution of peritoneal macrophage populations after intravenous injection in mice: differential effects of eliciting and activating agents. J Reticuloendothel Soc (1983) 0.82
Systemic and in situ natural killer and suppressor cell activities in mice bearing progressively growing murine sarcoma-virus-induced tumors. Int J Cancer (1981) 0.82
Divergent effects of dithiocarbamates on AP-1-containing and AP-1-less NFAT sites. Eur J Immunol (1999) 0.81
NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors: effect on inositol lipid turnover. Oncogene (1989) 0.81
Protein kinase C inhibitors block the activation of macrophages by IFN-beta but not by IFN-gamma. J Immunol (1988) 0.81
Prostaglandins inhibit lipoprotein lipase gene expression in macrophages. Immunology (1994) 0.80
Interactions of oncogenes with haematopoietic cells. Clin Haematol (1986) 0.80
Modulation of CD3- large granular lymphocyte functions by agonist and antagonists of protein kinase C: effects on NK and lymphokine-activated killer activity and production of IFN-gamma. J Immunol (1989) 0.80